missing translation for 'onlineSavingsMsg'
Learn More
  1. Home
  2. Products
  3. Buffers and Standards
  4. General Chemistry Solutions
  5. 01002010

CERILLIANT™ Suvorexant-D6 Solution, 100 μg/mL in Methanol, Sold by MilliporeSigma™ Supelco™

Catalog No. 01002010
Change view
Click to view available options
Quantity:
1 mL
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
01002010 1 mL
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. 01002010 Supplier Merck Emd Millipore Supplier No. S1151ML
Only null left

Description

Certified reference material

Suvorexant, sold under the trade name Belsomra, is a medication for the treatment of insomnia, approved for sale by the U.S. Food and Drug Administration (FDA) in 2014. The U.S. Drug Enforcement Administration (DEA) has scheduled this substance as controlled substance, as it may lead to physical or psychological dependence. This stable-labeled internal standard is suitable for use in quantitation of suvorexant levels by GC/MS or LC/MS for applications in clinical toxicology, therapeutic drug monitoring or urine drug testing.

Specifications

CAS 67-56-1
Linear Formula C23H17D6ClN6O2
UN Number UN 1230 - class 3 - PG 2 - Methanol, solution
Concentration 100 μg/mL in methanol
Formula Weight 456.96
Packaging Ampule
Quantity 1 mL
Flash Point 9.7°C (49.5°F) - closed cup

CERILLIANT is a registered trademark of Cerilliant Corporation